Netherlands
I am a strategy-driven clinical development professional with a PhD in Medical Sciences, working at the intersection of clinical research, medical insight generation, and trial execution. In my current role as Clinical Medical Manager at Novo Nordisk, I contribute to global clinical development programs in cardiorenal and metabolic disease. I focus on translating clinical practice, patient pathways, and stakeholder insights into actionable input for study feasibility, trial design, and execution. By working closely with global study teams and medical affairs, I help ensure that clinical trials are not only scientifically robust, but also feasible and relevant within real-world healthcare settings. My experience spans the full drug development continuum; from early-stage research in nephrology and drug discovery to clinical trial execution and strategy. This enables me to connect scientific innovation with clinical reality and to contribute to development decisions from multiple perspectives. I particularly enjoy working in a cross-functional environment and engaging with investigators and key opinion leaders to understand clinical needs and challenges. I am motivated by roles where I can shape clinical development strategy, improve trial relevance, and ultimately contribute to better outcomes for patients.
Act as a clinical and medical strategy partner contributing to the design, feasibility, and execution of global clinical development programs within cardiorenal and metabolic disease, including CKD, ASCVD, heart failure, type 2 diabetes and obesity. Drive country-level clinical strategy by integrating local clinical insights into global development and trial execution.
Managed and monitored clinical trials (including FLOW and ZEUS) within cardiorenal and metabolic disease, ensuring compliance with GCP and regulatory standards while supporting high-quality trial execution. Built strong relationships with investigators and site staff to facilitate recruitment and retention, while proactively identifying and resolving operational challenges impacting timelines and data quality. This role provided deep insight into the practical execution of clinical trials and the complexities of site-level implementation, forming a strong foundation for subsequent strategic work in clinical development.
Contributed to the development of early-stage therapeutic strategies in nephrology by leveraging scientific expertise in renal physiology and molecular biology. Actively supported the shaping of the company’s pipeline and research direction, while initiating and driving collaborations with academic and industry partners. Played a key role in scientific discussions, project development, and successful external funding efforts, including participation in a EUROSTARS grant application, strengthening experience at the interface of science, strategy, and collaboration.
Worked within target discovery and validation to support the establishment of a new kidney disease research area, contributing to the identification and development of novel therapeutic targets. Engaged in cross-functional scientific collaboration, driving discussions with internal and external stakeholders to advance research programs. This role provided extensive experience in early drug discovery, multidisciplinary teamwork, and the translation of scientific insights into potential therapeutic strategies.
Provided scientific and technical support for molecular diagnostic applications (HLA typing), translating complex data into practical solutions for clinical and laboratory stakeholders. Gained early exposure to customer-facing engagement and real-world diagnostic workflows.
Conducted independent research in renal physiology, leading a multidisciplinary research project from concept to publication within the field of nephrology. Developed and applied innovative experimental approaches to investigate physiological mechanisms relevant to kidney function and disease. Managed the full research lifecycle, including experimental design, data generation, analysis, and dissemination of results through 7 peer-reviewed publications and several presentations at international conferences (e.g. ASN Kidney Week). Collaborated with internal and external stakeholders, contributing to scientific discussions and advancing research insights within the broader nephrology community. This experience provided a strong foundation in critical thinking, scientific rigor, and the ability to translate complex biological data into meaningful insights relevant for clinical research and drug development.